Engerix-B - Hepatitis B vaccine for immunization of patients with chronic hepatitis C

被引：0
|
作者：
不详
机构：
来源：
FORMULARY | 1998年 / 33卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：923 / 923
页数：1
相关论文
共 50 条
  • [21] Hepatitis B surface antigenemia in chronic hemodialysis patients: Effect of hepatitis B immunization
    Ly, D
    Yee, HF
    Brezina, M
    Martin, P
    Gitnick, G
    Saab, S
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (01): : 138 - 141
  • [22] COMPARISON OF ENGERIX-B AND HEPLISAV-B VACCINE SEROPROTECTION RATES IN DIALYSIS
    Manley, Harold J.
    Aweh, Gideon
    Frament, Jill
    Ladik, Vlad
    Lacson, Eduardo, Jr.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2021, 77 (04) : 623 - 623
  • [23] Recently Approved Heplisav-B® [Hepatitis B Vaccine (Recombinant), Adjuvanted] Shows a Lower Proportion of Subjects with Non-and Low Response Compared with Engerix-B® [Hepatitis B Vaccine (Recombinant)] in Pooled Analysis of Trials
    Hyer, Randall
    Janssen, Robert S.
    HEPATOLOGY, 2018, 68 : 231A - 232A
  • [24] Sci-B-VacTM Vs ENGERIX-B Vaccines for Hepatitis B Virus in Patients with Inflammatory Bowel Diseases: A Randomised Controlled Trial
    Etzion, Ohad
    Novack, Victor
    Perl, Yael
    Abel, Olga
    Schwartz, Doron
    Munteanu, Daniella
    Abufreha, Naim
    Ben-Yaakov, Gil
    Maoz, Eyal D.
    Moshaklo, Alex
    Dizingf, Vitaly
    Fich, Alex
    JOURNAL OF CROHNS & COLITIS, 2016, 10 (08): : 905 - 912
  • [25] IMMUNOGENICITY OF TWO DOSES OF INVESTIGATIONAL HEPLISAV™ (HBSAG-ISS) COMPARED TO THREE DOSES OF LICENSED HEPATITIS B VACCINE (ENGERIX-B®) IN DIABETICS
    Heyward, William L.
    Xie, Fang
    Halperin, Scott
    Martin, J. Tyler
    HEPATOLOGY, 2010, 52 (04) : 883A - 883A
  • [26] Hepatitis B vaccination in patients with chronic hepatitis C
    Lee, SD
    Chan, CY
    Yu, MI
    Lu, RH
    Chang, FY
    Lo, KJ
    JOURNAL OF MEDICAL VIROLOGY, 1999, 59 (04) : 463 - 468
  • [27] Use of hepatitis B vaccine for the treatment of chronic hepatitis B
    Ishikawa, Tetsuya
    Kakumu, Shinichi
    HEPATOLOGY RESEARCH, 2007, 37 : S347 - S350
  • [28] Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C
    Wiedmann, M
    Liebert, UG
    Oesen, U
    Porst, H
    Wiese, M
    Schroeder, S
    Halm, U
    Mösser, J
    Berr, F
    HEPATOLOGY, 2000, 31 (01) : 230 - 234
  • [29] IMMUNOGENICITY AND SAFETY OF TWO DOSES OF INVESTIGATIONAL HEPLISAV™ COMPARED TO THREE DOSES OF LICENSED HEPATITIS B VACCINE (ENGERIX-B®) IN TWO PHASE 3 TRIALS
    Janssen, R.
    Bennett, S.
    Namini, H.
    Heyward, W.
    Martin, J.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S574 - S574
  • [30] Long-term immunogenicity and safety of the hepatitis B vaccine HepB-CpG (HEPLISAV-B) compared with HepB-Eng (Engerix-B) in adults with chronic kidney disease
    Girndt, Matthias
    Houser, Patricia
    Manllo-Karim, Roberto
    Ervin, John E.
    Charytan, Chaim
    Chow, Stephen
    Symonian-Silver, Margarita
    Lehrner, Lawrence
    Linfert, Douglas
    Shemin, Douglas
    Michelsen, Ann
    Xie, Fang
    Janssen, Robert S.
    VACCINE, 2023, 41 (20) : 3224 - 3232
12345